Eil Therapeutics, Inc.

City:

San Diego, California

Country:

United States

Published Applications:

Last publication date:

2024-02-08

Patent Grants:

Last grant date:

2023-12-05

Top Inventors for applications by Eil Therapeutics, Inc.

These are the the leading inventors for applications assigned to Eil Therapeutics, Inc.:

Nikolay SAVCHUK 4 San Diego, CA United States
Andrew ORRY 4 San Diego, CA United States
Ruben Abagyan 4 La Jolla, CA United States
Alexei Pushechnikov 4 San Diego, CA United States

Alexandre Vasilievich IVACHTCHENKO 4 Hallandale Beach, FL United States
Vladislav Zenonovich PARCHINSKY 4 Moscow, Russian Federation
Polo Chun-Hung LAM 4 San Diego, CA United States
Volodymyr KYSIL 4 San Diego, CA United States

Recent patent applications by Eil Therapeutics, Inc.

Eil Therapeutics, Inc. based in San Diego, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-02-08

US20240043424A1

Chemistry; metallurgy

COMPOUNDS HAVING ((3-NITROPHENYL)SULFONYL)ACETAMIDE AS BCL-2 INHIBITORS

#2 | 2023-11-09

US20230357238A1

Chemistry; metallurgy

COMPOUNDS HAVING ((3-NITROPHENYL)SULFONYL)ACETAMIDE AS BCL-2 INHIBITORS

#3 | 2022-09-29 ✅ Patent 11,834,450 granted on 2023-12-05

US20220306625A1

Chemistry; metallurgy

Compounds having ((3-nitrophenyl)sulfonyl)acetamide as BCL-2 inhibitors

#4 | 2022-09-15 ✅ Patent 11,697,650 granted on 2023-07-11

US20220289745A1

Chemistry; metallurgy

Compounds having tetrahydroindolizine-1-carboxamide as BCL-2 inhibitors

Also check out Eil Therapeutics, Inc.'s (San Diego, United States) applicant profile with 3 patent applications submitted.

AssigneeID:

343584 ⎘